Cochrane · systematic review · CD013359

Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children

Kay, AW, Ness, T, Verkuijl, SE, et al. · Cochrane Database of Systematic Reviews · 2022 · Cochrane Library

Infectious Diseases2 versionsAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
5
No studies
2
Included studies
NR
No studies 2 · 28.6%Ungraded 0 · 0%Very low 2 · 28.6%Low 0 · 0%Moderate 2 · 28.6%High 1 · 14.3%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Show all 2 versions

Xpert Ultra for pulmonary tuberculosis in childrena

Population: children with presumed pulmonary tuberculosis Index tests: Xpert Ultra Role: an initial test Threshold for index tests: an automated result is provided Reference standard: culture Types of studies: cross‐sectional and cohort studies
5 questions
OutcomeEffectEvidenceStatus / GRADE
Specimen
no estimate extractedNRNo studies
Sputum
no estimate extracted5 studies · 127 participantsHigh
Gastric aspirate
no estimate extracted7 studies · 120 participantsModerate
Downgraded: imprecision
Stool
no estimate extracted6 studies · 200 participantsModerate
Downgraded: imprecision
Nasopharyngeal aspirate
no estimate extracted4 studies · 46 participantsVery low
Downgraded: imprecision, indirectness

Xpert Ultra for rifampicin resistancea

Population: children with presumed pulmonary tuberculosis Index tests: Xpert Ultra Role: an initial test Threshold for index tests: an automated result is provided Reference standard: culture‐based phenotypic drug susceptibility testing and MTBDRplus Types of studies: cross‐sectional and cohort studies
2 questions
OutcomeEffectEvidenceStatus / GRADE
Specimen
no estimate extractedNRNo studies
All specimens
no estimate extracted3 studies · 3 participantsVery low
Downgraded: risk of bias, imprecision, indirectness